- Report
- October 2024
- 190 Pages
Global
From €3222EUR$3,545USD£2,759GBP
€3580EUR$3,939USD£3,066GBP
- Report
- August 2024
- 92 Pages
Global
From €3500EUR$4,125USD£3,102GBP
- Report
- April 2025
- 50 Pages
Global
From €2409EUR$2,650USD£2,062GBP
Arecoline Hydrobromide is a drug used in the treatment of central nervous system disorders. It is a cholinergic agonist, meaning it stimulates the release of the neurotransmitter acetylcholine. It is used to treat conditions such as Alzheimer's disease, Parkinson's disease, and dementia. It is also used to treat myasthenia gravis, a neuromuscular disorder. Arecoline Hydrobromide is available in both oral and injectable forms.
Arecoline Hydrobromide is a relatively new drug, and its use is still being studied. It is believed to have potential in treating a variety of neurological disorders, but more research is needed to determine its efficacy.
Some companies in the Arecoline Hydrobromide market include Sun Pharmaceutical Industries, Lupin Pharmaceuticals, and Cadila Healthcare. These companies manufacture and distribute the drug in various forms. Show Less Read more